)
Humanwell Healthcare (600079) investor relations material
Humanwell Healthcare Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue rose 9.15% YoY to RMB6.35bn; attributable net income increased 103.27% to RMB1.09bn, while adjusted net income fell 5.10% to RMB507.9m.
YTD revenue grew 2.96% to RMB18.41bn and attributable net income rose 43.01% to RMB2.41bn; a stake sale contributed a reported RMB514m to current-period earnings.
Financial highlights
Q3 pretax profit was RMB1.49bn, up 77.09% YoY; YTD pretax profit was RMB3.49bn, up 32.55%.
YTD net income was RMB2.94bn, including RMB2.41bn attributable to shareholders and RMB529.2m to minority interests.
YTD basic and diluted EPS were RMB1.48, up 43.69%; Q3 basic and diluted EPS were RMB0.66, up 100%.
YTD operating cash flow was RMB1.78bn, up 8.07%; Q3 operating cash flow was RMB778.4m, down 1.41%.
Key financial ratios and metrics
Q3 weighted average ROE was 5.47%, up 2.60 percentage points; YTD ROE was 12.21%, up 3.01 points.
Total assets were RMB37.72bn at quarter-end, up 2.65% from year-end; equity attributable to shareholders was RMB20.37bn, up 7.72%.
- Net profit rose 15.15% year-over-year on stable revenue and improved operational efficiency.600079
H1 2026 - Net profit grew 8.85% year-over-year, with positive cash flow and planned equity financing.600079
Q1 2026 - Net profit jumped 39.53% to ¥1.86 billion despite a 5.79% revenue drop in 2025.600079
H2 2025 - Q3 2025 net profit rose 11.56% year-over-year, with improved cash flow and new financing deals.600079
Q3 2025 - Net profit grew 3.9% to ¥1.15B despite a 6.2% revenue drop, with improved cost controls.600079
H1 2025 - Q3 revenue and net profit rose year-over-year, while operating cash flow saw strong growth.600079
Q3 2024 - Revenue up 3.86%, net profit down 16.07%, strong pharma growth, cash flow surges.600079
H1 2024 - Net profit rose 11% despite revenue decline, with control likely shifting to China Merchants Group.600079
Q1 2025 - Revenue up 3.7%, net profit down 37.7%, strong R&D, high dividend, regulatory risk.600079
H2 2024
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)